Table of Content
Table of Content
1 Nuclear Medicine-Radiopharmaceuticals Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Nuclear Medicine-Radiopharmaceuticals
1.3 Nuclear Medicine-Radiopharmaceuticals Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Nuclear Medicine-Radiopharmaceuticals
1.4.2 Applications of Nuclear Medicine-Radiopharmaceuticals
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Nuclear Medicine-Radiopharmaceuticals Industry Trends
1.5.2 Nuclear Medicine-Radiopharmaceuticals Drivers
1.5.3 Nuclear Medicine-Radiopharmaceuticals Market Challenges
1.5.4 Nuclear Medicine-Radiopharmaceuticals Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Nuclear Medicine-Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Nuclear Medicine-Radiopharmaceuticals
2.2.1 Major Players Manufacturing Base of Nuclear Medicine-Radiopharmaceuticals in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
2.3.3 Labor Cost of Nuclear Medicine-Radiopharmaceuticals
2.4 Market Channel Analysis of Nuclear Medicine-Radiopharmaceuticals
2.5 Major Down Stream Customers by Application
3 Global Nuclear Medicine-Radiopharmaceuticals Market, by Type
3.1 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2018-2021)
3.2 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2018-2021)
3.3 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate of Diagnostic Medicine
3.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate of Therapeutic Medicine
3.4 Global Nuclear Medicine-Radiopharmaceuticals Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Nuclear Medicine-Radiopharmaceuticals Market, by Application
4.1 Downstream Market Overview
4.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2018-2021)
4.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2018-2021)
4.3.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2018-2021)
4.3.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2018-2021)
5 Global Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2018-2021)
5.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Region (2018-2021)
5.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.4.2 North America Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.5 Europe Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.5.2 Europe Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.6 China Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.6.2 China Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.7 Japan Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.7.2 Japan Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.8 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.8.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.9 India Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.9.2 India Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.10 South America Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.10.2 South America Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.11 South Korea Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.11.2 South Korea Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
5.12 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
5.12.2 Southeast Asia Nuclear Medicine-Radiopharmaceuticals SWOT Analysis
6 Global Nuclear Medicine-Radiopharmaceuticals Production by Top Regions (2018-2021)
6.1 Global Nuclear Medicine-Radiopharmaceuticals Production by Top Regions (2018-2021)
6.2 North America Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate
6.3 Europe Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate
6.4 China Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate
6.5 Japan Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate
6.6 India Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate
7 Global Nuclear Medicine-Radiopharmaceuticals Consumption by Regions (2018-2021)
7.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption by Regions (2018-2021)
7.2 North America Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.3 Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.4 China Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.5 Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.6 Middle East & Africa Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.7 India Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.8 South America Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.9 South Korea Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
7.10 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Sigma Aldrich Corporation Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.2.3 Sigma Aldrich Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Jubilant Pharma Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.3.3 Jubilant Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Medtronic Plc Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.4.3 Medtronic Plc Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 GE Healthcare Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.5.3 GE Healthcare Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Eczacibasi-Monrol Nuclear Products Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.6.3 Eczacibasi-Monrol Nuclear Products Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Cardinal Health, Inc Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.7.3 Cardinal Health, Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Bayer AG Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.8.3 Bayer AG Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Lantheus Medical Imaging, Inc Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.9.3 Lantheus Medical Imaging, Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Advanced Accelerator Applications S.A. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.10.3 Advanced Accelerator Applications S.A. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Iba Molecular Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.11.3 Iba Molecular Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Bracco Imaging S.P.A Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.12.3 Bracco Imaging S.P.A Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Siemens Healthcare Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.13.3 Siemens Healthcare Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Nordien, Inc Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.14.3 Nordien, Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Nordion, Inc Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.15.3 Nordion, Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Mallinckrodt PLC Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
8.16.3 Mallinckrodt PLC Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis and Forecast by Type and Application
9.1 Global Nuclear Medicine-Radiopharmaceuticals Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Diagnostic Medicine Market Revenue and Volume Forecast (2021-2026)
9.1.2 Therapeutic Medicine Market Revenue and Volume Forecast (2021-2026)
9.2 Global Nuclear Medicine-Radiopharmaceuticals Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 SPECT Market Revenue and Volume Forecast (2021-2026)
9.2.2 PET Market Revenue and Volume Forecast (2021-2026)
9.2.3 Therapeutic Market Revenue and Volume Forecast (2021-2026)
10 Nuclear Medicine-Radiopharmaceuticals Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Nuclear Medicine-Radiopharmaceuticals Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
